Maddox Attends First FDA Digital Health Advisory Committee Meeting

Maddox Attends First FDA Digital Health Advisory Committee Meeting
Thomas Maddox, MD, MSc, vice president of Digital Products and Innovation for BJC HealthCare and a professor in the Cardiovascular Division, has been appointed to the inaugural FDA Digital Health Advisory Committee. The committee will advise the Commissioner of the Food and Drug Administration on digital health technologies (DHT’s) and guide on policies and regulations for their use. The first meeting was held in late November 2024 and focused on generative artificial intelligence (GenAI) and its use in healthcare.

Leadership Announcement – Interventional Cardiology (Links to an external site)

Leadership Announcement – Interventional Cardiology
I am pleased to announce that Dr. Marc Sintek, Associate Professor of Medicine and Director of the Interventional Cardiology Fellowship, has been appointed as the next Director of the BJH Cardiac Catheterization Laboratory. Dr. Sintek has served as Associate Director of the Cath Lab since 2023 and will take the reins from Dr. Jas Singh

Agarwal, Huffman, and Hively Publish in JACC: Advances on Polypill Trials

Agarwal, Huffman, and Hively Publish in JACC: Advances on Polypill Trials
In a new paper published in JACC: Advances, Drs. Anubha Agarwal, Mark Huffman, and Global Health Clinical Research Coordinator Adam Hively, MPH examine the history of polypill trials. The paper, titled “More Than a Decade of Atherosclerotic Cardiovascular Disease Polypill Trials: Lessons for Heart Failure Polypills” marks the first publication for Hively, as the Global Health team within the WashU cardiovascular division continues research into this lifesaving therapy.